About Reckon Pharmachem Private Limited
Data last updated:
Reckon Pharmachem Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 18 October 2001.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL2001PTC186327. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹10 Cr and a paid-up capital of ₹10 Cr. It was formerly known as Nb Welcome Chemicals Private Limited. It was led by directors Mohanan Karunakaran and Vimal Aggarwal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at C – 562 New Friends Colony, New Delhi, Delhi, India – 110025.
As per the financials filed for FY 2024, the company reported a revenue of ₹23.01 Lakh. For the same year it recorded a net loss of ₹1.11 Cr (net margin -483.4%) and EBITDA of -₹1.21 Cr. Revenue has grown at a compounded annual rate (CAGR) of 76% over five years.
As per MCA filings, the company had satisfied charges of ₹18.85 Cr on record. Court records list 13 cases involving the company, including 12 filed by the company and 1 filed against it. The company has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹9 Cr; the latest was in March 2015. Its 10 peer companies in the Pharma industry (API Manufacturers) are compared by revenue, 5 larger and 5 smaller; the largest is JMVH Exim Services Private Limited with revenue of ₹26.32 Lakh.
The last known website on record is reckon.in.
Company details
CIN history
Reckon Pharmachem has one previous CIN (Corporate Identification Number): U24231MH2001PTC133726. The current CIN is U24231DL2001PTC186327, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231DL2001PTC186327 | Current |
| U24231MH2001PTC133726 | Previous |
Contact details
Reckon Pharmachem Private Limited's registered office is in New Delhi, Delhi. Its website is reckon.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressC – 562 New Friends Colony, New Delhi, Delhi, India – 110025
- IndustryPharma, API Manufacturers
To see the full contact details of Reckon Pharmachem Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Reckon Pharmachem Private Limited
FY 2024 filings availableReckon Pharmachem Private Limited reported revenue of ₹23.01 Lakh for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 76% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.21 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.11 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | -483.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Reckon Pharmachem Private Limited, buy the company report.
Board of directors of Reckon Pharmachem Private Limited
Reckon Pharmachem has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohanan Karunakaran Also directs: Demaco Polymers Limited, Reckon Petrochem Limited | Director | 15 Dec 2018 | 7 Years 10 Months | As last reported |
| Vimal Aggarwal Also directs: Ruchi India Limited, Gold Wind Build Project Private Limited, Demaco Polymers Limited and 1 more | Director | 01 Jul 2016 | 10 Years 3 Months | As last reported |
Peer comparison
Reckon Pharmachem Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| JMVH Exim Services Private Limited | ₹26.32 Lakh (FY 2025) | -28.0% | Village Chandkheda, Gujarat, India | |||
| Celaxis Bioscience Private Limited | ₹26.05 Lakh (FY 2025) | 266.0% | Himatnagar, Gujarat, India | |||
| Somu Protopack Private Limited | ₹25.6 Lakh (FY 2025) | Btm Layout, Bangalore, Karnataka, India | ||||
| Oram Biochem Private Limited | ₹23.91 Lakh (FY 2025) | Pune, Maharashtra, India | ||||
| Octanex Labs Private Limited | ₹23.33 Lakh (FY 2024) | 242.0% | Hyderabad, Telangana, India | |||
| Reckon Pharmachem Private Limitedthis company | ₹23.01 Lakh (FY 2024) | -₹1.11 Cr | -483.4% | New Delhi, Delhi, India | ||
| Analytica Labchem Private Limited | ₹22.25 Lakh (FY 2024) | 2.0% | Mumbai, Maharashtra, India | |||
| Vaaman Laboratories Private Limited | ₹21.72 Lakh (FY 2024) | -78.0% | Hyderabad, Telangana, India | |||
| Vardhman Life Sciences Private Limited | ₹21.06 Lakh (FY 2015) | -66.0% | New Delhi, Delhi, India | |||
| Anmol Antioxidants Pvt Ltd | ₹20.76 Lakh (FY 2021) | -93.0% | Ankleshwar, Gujarat, India | |||
| Amogen Pharma Private Limited | ₹20.33 Lakh (FY 2025) | Hyderabad, Telangana, India |
To see the full peer comparison of Reckon Pharmachem Private Limited, buy the company report.
Auditor
Reckon Pharmachem Private Limited is audited by SUNITA AND CHADHA for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUNITA AND CHADHA | FY 2022 | 003426N |
Shareholding
The shareholding of Reckon Pharmachem Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Reckon Pharmachem Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Jul 2004 | 90148802 | State Bank of India | ₹18.85 Cr | Satisfied |
To see the full charge records of Reckon Pharmachem Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Reckon Pharmachem Private Limited has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹9 Cr; the latest was in March 2015.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Ruchi India Limited , Gandhar Export Limited, an individual |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: Gandhar Export Limited Seller: an individual |
| Sep 2009 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Feb 2009 | Funding round | ₹5.5 Cr | Investors: Ruchi India Limited , 2 individuals |
| Mar 2007 | Funding round | ₹3.5 Cr | Investors: Gandhar Export Limited, Ruchi India Limited , 2 individuals |
To see the full deal history of Reckon Pharmachem Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Reckon Pharmachem Private Limited has 13 court cases on record: 12 filed by Reckon Pharmachem, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 13 | 1 | 0 |
Cases on record (3 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Civil suit | Filed against the company by HDFC Bank Ltd. | Disposed |
| District court, South East, Delhi | Revision petition | Filed by the company against an individual | Disposed |
| District court, Vadodara, Gujarat | Criminal complaint | Filed by the company against Bru Medicomints Ltd | Disposed |
To see the full case history of Reckon Pharmachem Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Reckon Pharmachem Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Reckon Pharmachem Private Limited has 1 active EPFO establishment as of Mar 21, 2024.
GST
Reckon Pharmachem has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Reckon Pharmachem Private Limited, buy the company report.
Recent activity
Reckon Pharmachem Private Limited has 9 board changes on record since 2007: 2 appointments and 7 cessations. The latest: Mohanan Karunakaran ceased to be Additional Director on 04 Jan 2019.
3 earlier events are in the company report.
Frequently asked questions
Reckon Pharmachem has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Reckon Pharmachem was a private limited company based in New Delhi, Delhi, India. The company worked in api manufacturers, within the pharma industry. It was incorporated on 18 October 2001 and is registered under CIN U24231DL2001PTC186327. The company has been struck off by the Registrar of Companies and is no longer operational.
Reckon Pharmachem had 2 directors:
- Mohanan Karunakaran - Director
- Vimal Aggarwal - Director
The CIN (Corporate Identification Number) of Reckon Pharmachem is U24231DL2001PTC186327. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Reckon Pharmachem is at C – 562 New Friends Colony, New Delhi, Delhi, India – 110025.
Reckon Pharmachem was incorporated on 18 October 2001. It is registered with the Registrar of Companies, Delhi.
Reckon Pharmachem can be reached through the website reckon.in. Its registered office is in New Delhi, Delhi, India.
The latest financial statements of Reckon Pharmachem on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
No. Reckon Pharmachem has 1 GST registration on record and it is cancelled or inactive.
Reckon Pharmachem operated in the pharma industry, in the api manufacturers segment. It worked in this industry before it was struck off.
Reckon Pharmachem has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹9 Cr; the latest was in March 2015.